What is Upstream Bio, Inc.'s change in accrued liabilities?

Upstream Bio, Inc. (UPB) reported change in accrued liabilities of $1.23M in Q1 2026.

How has Upstream Bio, Inc.'s change in accrued liabilities changed year-over-year?

Upstream Bio, Inc.'s change in accrued liabilities increased by 166.4% year-over-year, from -$1.85M to $1.23M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Upstream Bio, Inc. UPB Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

AmgenAMGN

-$959M-9.7%

Aclaris TherapeuticsACRS

-$3.03M+72.6%

Shattuck Labs, Inc.STTK

-$1.96M-173%

Avalo TherapeuticsAVTX

-$1.5M+12.1%

Theravance BiopharmaTBPH

-$4.87M-221%

MoonLake ImmunotherapeuticsMLTX

$7.12M+558%

Other financials

Income statement

See full

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

See full

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

See full

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

See full

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

See full

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

See full

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Upstream Bio, Inc.'s change in accrued liabilities?: Upstream Bio, Inc. (UPB) reported change in accrued liabilities of $1.23M in Q1 2026.
How has Upstream Bio, Inc.'s change in accrued liabilities changed year-over-year?: Upstream Bio, Inc.'s change in accrued liabilities increased by 166.4% year-over-year, from -$1.85M to $1.23M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.